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Heteroditopic receptors (4a–e) based on a thiacalix[4]arene in the 1,3-alternate conformation, which have
two urea moieties linking various phenyl groups substituted with either electron-donating or
-withdrawing groups at their m-, or p-positions with a crown-ether moiety at the opposite side of the
thiacalix[4]arene cavity, have been synthesized. The two examples with p-CH3– (4b) and p-NO2-
substituted (4e) phenyl groups have been characterized by X-ray crystallography. The binding properties
of receptor 4e were investigated by means of
1H NMR spectroscopic and absorption titration
experiments in CHCl3–DMSO (10 : 1, v/v) solution in the presence of K
+ ions and various anions.
Interestingly, it was found that receptor 4e, which possesses two p-nitrophenyl ureido moieties, can
complex most eﬃciently in the urea cavity or the crown-ether moiety; and the plausible allosteric eﬀect
of receptor 4e was also studied.Introduction
The use of calix[n]arenes1 as building blocks for receptors
capable of the highly selective recognition of cations, anions or
neutral molecules has received considerable attention in the
eld of supramolecular chemistry. Among the various kinds of
calix[n]arenes available, thiacalix[4]arenes2,3 are proving to be
competent scaﬀolds and are nding wide use, for example as
chemosensors, as well as in catalysis because of their favourable
conformational properties, easy functionalization and
emerging metal coordination chemistry. Several kinds of
systems based on thiacalix[4]arenes are suitable for allosteric
regulation4 of host–guest interactions with metal cations, and
these contribute greatly to organic processes in biological
systems. Anions also play an important role in biological
processes, and are closely related with biological systems such
as DNA and enzyme substrates. The development and the
investigation of anion selective sensors5 have attractedlty of Science and Engineering, Saga
Japan. E-mail: yamatot@cc.saga-u.ac.jp
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025, China
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hemistry 2015considerable interest. However, it is more diﬃcult to
accomplish compared with metal cation sensors because
anions can possess structures of diﬀerent shapes,6 typically
spherical (F, Cl, Br, I), Y-shaped (AcO, PhCOO) or
tetrahedral (H2PO4
). In recent years, anion receptors based
on calix[n]arenes have become an active research topic. Calix-
[n]arene urea derivatives are eﬃcient for anion recognition
given the hydrogen-bonding interaction between anions and
N–H protons which can occur.
Colorimetric chemosensors7,8 have also attracted attention
due to some desirable features such as easy detection by the
naked eye, construction of simple, low-cost devices and so on.
Many colorimetric anion receptors containing a variety of
chromogenic signaling units such as indole, imidazolium,
benzenediimide, 4-nitrophenylazo, diazo and anthraquinone
groups have been developed. Furthermore, numerous colori-
metric anion sensors utilizing a variety of structural scaﬀolds,
which contain urea groups, have been investigated and proved
to be eﬃcient naked-eye detectors for various anions. However,
there are a few reports on the development of colorimetric
chemosensors based calix[4]arene type scaﬀolds.8l,p
Lhota´k9 and co-workers have reported anion receptors based on
either an upper rim substituted calix[4]arene or thiacalix[4]-arene,
which contains two p-nitrophenyl or p-tolyl ureido moieties.9a–c,h
These anion receptors exhibited eﬀective recognition abilities
towards selected anions in common organic solvents. Moreover,
Kumar10 and co-workers reported an anion receptor bearing a
calix[4]arene in the 1,3-alternate conformation, which contains two
p-nitrophenyl moieties.10g This compound exhibited strong
binding and good selectivity for Cl ion due to the formation ofRSC Adv., 2015, 5, 14747–14755 | 14747
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View Article Onlinestrong hydrogen bonds between the Cl ion and N–H protons in
common organic solvents. However, investigations concerning the
appearance of an allosteric eﬀect in analogues based on the
interaction of thiacalix[4]arene and alkalimetal cations and anions
has not yet been reported.
Herein, we have independently designed a heterodimeric
system11 based on a thiacalix[4]arene having two diﬀerent side
arms, viz two ureas moieties linking various phenyl groups
bearing either electron-donating or -withdrawing groups at
their m-, or p-positions. The calixarene also has a crown ether
moiety at the opposite side of the thiacalix[4]arene cavity. We
herein put forward the hypothesis (and then demonstrate) that
the heterodimeric system, which is controlled by the complex-
ation of the opposing side arms with anions and K+ ion, exhibits
eﬀective positive and negative allosteric eﬀects.
Results and discussions
Synthesis
The O-alkylation of distal-1 was carried out with 1.5 equivalents
of tetraethyleneglycol ditosylate in the presence of an equivalent
of K2CO3 according to the reported procedure, and aﬀorded the
desired 1,3-alternate-2 in 83% yield.12 The hydrazinolysis of
1,3-alternate-2 was carried out with a large excess of hydrazine
hydrate, and aﬀorded the desired 1,3-alternate-3 in 86% yield.
The condensation of 1,3-alternate-3 with 2.2 equivalents of the
appropriate isocyanate in THF furnished the receptors 4a–e in
good to excellent yields (Scheme 1). In general, the 1H NMR
spectrum of receptors 4a–e in CDCl3–DMSO (10 : 1, v/v) exhibi-
ted the characteristics of a 1,3-alternate conformation such as
two singlets (18H each) for the tert-butyl protons, one singlet
(4H) for OCH2CO protons, two singlets (4H each) for aromatic
protons and two singlets (2H each) for four urea NH protons.
The molecular structures of receptors 4b and 4e were also
veried by X-ray crystallographic analysis (Fig. 1 and S15 and
S16†). Receptors 4b and 4e were recrystallized from a mixture of
CHCl3–CH3CN (1 : 1, v/v) by slow evaporation. These results
indicate that receptors 4b and 4e adopt the 1,3-alternateScheme 1 Synthesis of receptors 1,3-alternate-4a–e.
Fig. 1 X-ray crystal structure of receptor 4e. H-bonds shown as
dashed lines. One of two similar molecules in the asymmetric unit is
shown in two orientations rotated by approx. 90. H atoms not
involved in H-bonding, minor disorder components, and chloroform
molecules of crystallization are omitted for clarity.
14748 | RSC Adv., 2015, 5, 14747–14755 This journal is © The Royal Society of Chemistry 2015
Table 1 Association constants of receptor 4a–e with Cl
 ionsa,b
Host 4a 4b 4c 4d 4e
R H p-CH3 p-CF3 3,5-(CF3)2 p-NO2
Ka [M
1] 6816  545 3021  242 12 813  1025 6945  625 34 411  2400
a Measured in CDCl3–DMSO (10 : 1, v/v) at 298 K by the
1H NMR titration method using the chemical-shi change of the NHa proton (Fig. S17–S22);
host concentration was 4.0  103 M. b Guests used: Bu4NCl.
Fig. 2 UV-vis absorption spectra of receptor 4e (2.5 mM) upon the
addition of Bu4NCl (0–50 mM) in CH2Cl2–DMSO (10 : 1, v/v).
Fig. 3 Binding mode of receptor 4e upon complexation with Cl
 ions.
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View Article Onlineconformation in the solid state. There are two thiacalixarenes,
one water molecule and three chloroform molecules in the
asymmetric unit. Interestingly, it was found that two urea
groups approach each other and are oriented in parallel due to
the existence of dual intramolecular hydrogen bonding (in
case of receptor 4e, for the molecule shown: N(14)–H(14)/
O(21) 2.37(2); N(15)–H(15)/O(21) 2.05(2) A; for the second
molecule: N(2)–H(2)/O(10) 2.37, N(3)–H(3)/O(10) 1.94(2) A)
(Fig. 1 and S16†). Moreover, the thiacalix[4]-arene-
monocrown-5 has a three-dimentional cavity and is large
enough to accommodate the metal cation. The association
constants (Ka values) between the receptors 4a–e and Cl
 ion
were determined by 1H NMR spectroscopic titration experi-
ments (Table 1). These results suggest that the association
constants depend on the electron-donating/withdrawing groups
located at the m-, or p-positions. In the presence of the electron-
withdrawing groups, such as CF3 (receptors 4c and 4d) and NO2
(receptor 4e), the Ka values were greater than that for the
unsubstituted receptor (receptor 4a). In contrast, in the case of
receptor 4b, possessing the electron-donating Me group, there
was a general decrease in the Ka value upon complexation with
Cl ion in comparison with the unsubstituted receptor 4a.
Therefore, the introduction of electron-withdrawing groups at
the m-, or p-positions appears to increase the acidity of the urea
protons, and hence enhance the anion-binding ability through
hydrogen-bonding interactions. The Ka value of receptor 4e with
the electron-withdrawing NO2 group at the p-position was the
best out of all the Ka values measured for receptors 4a–e and Cl

ion. Interestingly, it was found that the Ka value of receptor 4cThis journal is © The Royal Society of Chemistry 2015with the electron-withdrawing CF3 group at the p-position was
greater than that of receptor 4d with the electron-withdrawing
CF3 group at the m-position. This result indicates that
electron-withdrawing groups located at the p-position can
signicantly inuence the acidity of the urea protons by
conjugating with the phenyl groups. From the above, it is clear
that receptor 4e with the electron-withdrawing NO2 group at the
p-position has the most eﬀective recognition ability toward
selected anions. Given this, further complexation studies of
receptor 4e (2.5 mM) exhibits an absorption band at 310 nm in
the UV spectrum in the absence of anions. Upon addition of Cl
ion (0–50 mM) to the solution of receptor 4e, Fig. 2 reveals a
gradual decrease in the absorption of the band at 310 nm with a
simultaneous increase in the absorption at 340 nm. Meanwhile,
a clear isosbestic point was observed at 322 nm for the receptor
4e. A Job's plot binding between the receptor 4e and Cl
 ion
reveals a 1 : 1 stoichiometry (Fig. S25†), whilst the association
constant (Ka value) for the complexation with Cl
 ion by receptor
4e was determined to be 34 152 M
1 by UV-vis titration experi-
ments in CHCl3–DMSO (10 : 1, v/v) (Fig. S24, S27–S31†). More-
over, the concentration dependence of the 1H NMR chemical
shis of the ureido protons in receptor 4e was not observed
(Fig. S23†). This result suggests that receptor 4e has a strong
intramolecular hydrogen bond between the two ureas linking
the p-nitrophenyl moieties. These results strongly suggested
that Cl ion recognition by receptor 4e was via a hydrogen-
bonding interaction between the Cl ion and N–H protons asRSC Adv., 2015, 5, 14747–14755 | 14749
Fig. 5 Partial 1H NMR spectra of receptor 4e/guest (H/G ¼ 1 : 1); free
receptor 4e and in the presence of 1 equiv. of Bu4NX (X ¼ F, Cl, Br, I,
AcO, PhCOO, H2PO4). Host concentration was 2.5 mM. Solvent:
CDCl3–DMSO (10 : 1, v/v). 300 MHz at 298 K. *Denotes the solvent
peak.
Fig. 4 UV-vis absorption spectra of receptor 4e (2.5 mM) upon the
addition of Bu4NF (0–50 mM) in CH2Cl2–DMSO (10 : 1, v/v).
Table 2 Association constants of receptor 4e with various anions
a,b
Anion F Cl Br I AcO PhCO2
 H2PO4

Shape Spherical Spherical Spherical Spherical Y-shape Y-shape Tetrahedral
Ka [M
1] 128 775  10 302 34 152  2732 7296  584 4540  363 107 298  8584 106 743  8539 108 687  8695
a Measured in CH2Cl2–DMSO (10 : 1, v/v) at 298 K by UV-vis titration method (Fig. 2, 4, S24 and S27–S31); host concentration was 2.5 mM.
b Guests
used: tetrabutylammonium salt.
Fig. 6 Proposed positive allosteric behaviour of receptor 4e with Br

and K+ ions. Partial 1H NMR spectra of 4e/guest (H/G¼ 1 : 1); (a) free 4e;
(b) 4eIKSO3CF3; (c) Bu4NBr3[4eIK
+]; (d) 4eIBu4NBr. Solvent:
CDCl3–DMSO (10 : 1, v/v). 300 MHz at 298 K. *Denotes the solvent
peak.
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View Article Onlineshown in Fig. 3. Similarly, the UV-vis titration experiments of
receptor 4e with other various anions besides Cl
 ion were
carried out, and the Ka values are summarized in Table 2. As a
result, it was found that receptor 4e exhibited high selectivity
towards F ion amongst all of the anions tested, and was
capable of complexing with all of the anions tested, irrespective
of their shape. Interestingly, the color of the receptor 4e solution
changed from colorless to dark yellow upon addition of F ion (5
equivalents), and this could be easily observed by the naked eye.
Upon the addition of F ions (0–50 mM) to the solution of the14750 | RSC Adv., 2015, 5, 14747–14755receptor 4e, the absorption peak at 342 nm gradually moved to a
longer wavelength, nally reaching a maximum value at 360 nm
(Fig. 4 and S26†). This result suggests that the quinoid structure
was formed by the deprotonation of urea NH groups in the p-
nitrophenyl ureido moiety. Moreover, the addition of F, AcO,
PhCOO or H2PO4
 (1 equivalent) to solutions of receptor 4e in
CHCl3–DMSO (10 : 1, v/v) during the
1H NMR titration experi-
ments resulted in the disappearance of the urea proton signals,
NHa and NHb (Fig. 5). These results indicate that strong inter-
actions between these anions and the urea NH groups in the
receptor 4e occur and that the kinetics of these anion exchanges
is on the NMR time scale. On the other hand, 1H NMR spec-
troscopic and UV-vis titration experiments of receptor 4e with K
+
ion at the crown-ether moiety were also carried out (Fig. S32 and
S33†). When only K+ ion (1 equivalent) were added, not only the
downeld shi of the crown-ether bridge protons was observed,
but also all the NH protons in 1H NMR titration experiments
(Fig. 6b and 7b). It was found that a Job's plot binding betweenThis journal is © The Royal Society of Chemistry 2015
Fig. 7 Proposed negative allosteric behaviour of 4e with Cl
 and
K+ ions. Partial 1H NMR spectra of 4e/guest (H/G ¼ 1 : 1); (a) free 4e; (b)
4eIKSO3CF3; (c) Bu4NCl3[4eIK
+]; (d) 4eIBu4NCl. Solvent: CDCl3–
DMSO (10 : 1, v/v). 300 MHz at 298 K. *Denotes the solvent peak.
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View Article Onlinereceptor 4e and K
+ ion exhibited a 1 : 1 stoichiometry and that
the Ka value for the complexation with K
+ ion was determined to
be 28 536 (1998) M1 by UV-vis titration experiments in
CH2Cl2–DMSO (10 : 1, v/v) (Fig. S34 and S35†). These results
suggest that the crown-5 ring of receptor 4e binds K
+ ion. To seek
more detailed information about the presence of an eﬀective
positive or negative allosteric eﬀect between receptor 4e$K
+ and
Br or Cl ions, 1H NMR spectroscopic and UV-vis titration
experiments in CHCl3–DMSO (10 : 1, v/v) (Fig. S36†) were
carried. Fig. 6 reveals that when Br ion were added to the
solution of [4eIKSO3CF3] (Fig. 6c), the addition induces a
downeld shi of 0.42 ppm (d ¼ 9.09 to 9.51 ppm) for the NHa
protons, and upeld shis of 0.85 ppm (d ¼ 8.95 to 8.10 ppm)
for the NHb protons and of 0.29 ppm (d ¼ 8.10 to 7.81 ppm) for
the NHc protons, while the chemical shis for the crown-ether
bridge protons did not change. These results suggested the
formation of a heteroditopic dinuclear complex of the type
Br3[4eIK
+] (Fig. 6c), and we propose a positive allosteric
eﬀect of receptor 4e towards Br
 ions in the presence of K+ ion by
an ion-pair electrostatic interaction and a conformational
change of the exible thiacalix[4]arene cavity as shown in
Fig. 6. On the other hand, Fig. 7 shows that when Cl ions were
added to the solution of [4eIKSO3CF3] (Fig. 7c), this addition
induces a downeld shi of 1.11 ppm (d¼ 9.09 to 10.2 ppm) for
the NHa protons and 0.04 ppm (d ¼ 8.10 to 8.14 ppm) for the
NHc protons, and an upeld shi of 0.37 ppm (d ¼ 8.95 to 8.58
ppm) for the NHb protons, together with upeld shis for the
crown-ether bridge protons. Interestingly, when Cl ions were
added to the solution of [4eIKSO3CF3] (Fig. 7c), the chemical
shis for the crown-ether bridge protons most closely matched
the chemical shis for the free crown-ether bridge protonsThis journal is © The Royal Society of Chemistry 2015(Fig. 7c and d). These results suggested that the two urea groups
in two p-nitrophenyl ureido moieties of receptor 4e$K
+ bind the
Cl ion by an ion-pair electrostatic interaction and a confor-
mational change of the exible thiacalix[4]arene cavity. This
induces the decomplexation of the K+ ion from the crown-5 ring
of receptor 4e because the Cl
 ion has a smaller ionic radius and
therefore an increase in basicity in comparison with the Br ion,
and a negative allosteric eﬀect of receptor 4e to Cl
 ion in the
presence of K+ ion as shown in Fig. 7 is proposed.Conclusion
In summary, a new family of heteroditopic receptors (4a–e)
based on a thiacalix[4]arene in the 1,3-alternate conformation,
which has two ureas moieties bearing various phenyl groups
substituted with either electron-donating or -withdrawing
groups at their m-, or p-positions, as well as a crown-ether
moiety at the opposite side of thiacalix[4]arene cavity, has
been synthesized. By using 1H NMR spectroscopic and UV-vis
titration experiments, receptor 4e possessing an electron-
withdrawing NO2 group at the p-position has the most eﬀec-
tive recognition ability towards the selected anions. The binding
of K+ ions and various anions at the crown-5 ring moiety and the
two urea NH groups in two p-nitrophenyl ureido moieties,
respectively, was investigated. The results indicated the
complexation mode, and it was found that receptor 4e was able
to bind all of the anions tested, irrespective of their shape.
Receptor 4e exhibited highest selectivity towards F
 ion
amongst all of the anions tested and indicated that this receptor
might be a promising candidate as a colorimetric chemosensor.
The appearance of positive and negative allosteric eﬀects in
receptor 4ewas also investigated by
1H NMR and UV-vis titration
experiments. Interestingly, the formation of a heteroditopic
dinuclear complex of receptor 4e with Br
 and K+ ions by a
positive allosteric eﬀect could be observed. On the other hand,
the fact that two urea NH groups in two p-nitrophenyl ureido
moieties of receptor 4e$K
+ bind the Cl ion, which then induces
the decomplexation of the K+ ion from the crown-5 ring, is
indicative of a negative allosteric eﬀect.Experimental section
General
All melting points were determined with Yanagimoto MP-S1. 1H-
NMR spectra were determined at 300 MHz with a Nippon Denshi
JEOL FT-300 NMR spectrometer with SiMe4 as an internal refer-
ence; J-values are given in Hz. UV spectra were measured by a
Shimadzu 240 spectrophotometer. Mass spectra were obtained
on a Nippon Denshi JMS-01SG-2 mass spectrometer at an ioni-
zation energy of 70 eV using a direct inlet system through GLC.
Elemental analyses were performed by Yanaco MT-5.Materials
Unless otherwise stated, all other reagents used were purchased
from commercial sources and used without further purication.RSC Adv., 2015, 5, 14747–14755 | 14751
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View Article OnlineCompounds 113 and 212 were prepared following the reported
procedures.
Synthesis of compound 3
Compound 2 (1.0 g, 0.95 mmol) was put into a round-bottom
ask and ethanol (120 mL), THF (120 mL) and hydrazine
hydrate (14 mL, large excess) were added and reuxed for 48 h.
Aer cooling, the solvents and excess hydrazine were removed
under reduced pressure to give the crude product as a white
solid. The residue was triturated sequentially with water and
methanol and the product collected by ltration. Compound 3
was obtained 0.84 g (86%) as a white solid. M.p. 216–218 C. IR:
nmax (KBr)/cm
1: 3421, 2961, 1670, 1438, 1263, 1091, 1019 and
801. 1H NMR (300 MHz, CDCl3): d ¼ 1.25 (18H, s, tBu  2), 1.37
(18H, s, tBu 2), 3.00 (4H, t, J¼ 9.1 Hz, OCH2 2), 3.39 (4H, br,
OCH2 2), 3.48 (4H, br, NH2 2), 3.60 (4H, broad s, OCH2 2),
3.96 (4H, t, J ¼ 9.1 Hz, OCH2  2), 4.55 (4H, s, OCH2CO  2),
7.35 (4H, s, Ar-H  2), 7.41 (4H, s, Ar-H  2) and 7.54 (2H, s, NH
 2) ppm. 13C NMR (100 MHz, CDCl3): d ¼ 30.5 (CH3), 33.5
(C(CH3)3), 64.9 (OCH2), 67.4 (OCH2), 69.2 (OCH2), 70.5 (OCH2),
72.6 (OCH2), 126.2 (ArC), 126.4 (ArC), 126.5 (ArC), 126.7 (ArC),
146.5 (ArC), 146.7 (ArC), 153.6 (ArC), 155.4 (ArC) and 167.6 (CO)
ppm. FABMS: m/z: 1023.38 (M+). C52H70N4O9S4 (1023.39): calcd
C 61.03, H 6.89, N 5.47. Found: C 61.33, H 6.79, N 5.57.
Synthesis of receptor 4a
To compound 3 (150 mg, 0.147 mmol) in THF (10 mL), was
added phenyl isocyanate (38 mg, 0.320 mmol) and the mixture
was stirred for at room temperature for 24 h under argon. The
resulting precipitate was collected by ltration, washed with
hexane to give receptor 4a as a white solid. Recrystallization
from CHCl3–CH3CN (4 : 1) gave receptor 4a (154 mg, 83%) as
white solid. M.p. 202–205 C. IR: nmax (KBr)/cm
1: 3270, 2956,
1674, 1547, 1442, 1263, 1221, 1153, 1091, 799 and 751. 1H NMR
(300 MHz, CDCl3–DMSO, 10 : 1): d ¼ 1.25 (18H, s, tBu  2), 1.39
(18H, s, tBu 2), 2.97 (4H, t, J¼ 9.1 Hz, OCH2 2), 3.40 (4H, br,
OCH2  2), 3.63 (4H, s, OCH2  2), 3.85 (4H, t, J ¼ 9.1 Hz, OCH2
 2), 4.59 (4H, s, OCH2CO  2), 6.95 (2H, t, J ¼ 7.3 Hz, phenyl-H
 2), 7.15 (4H, t, J ¼ 7.6 Hz, phenyl-H  4), 7.31 (4H, d, J ¼ 7.7
Hz, phenyl-H  2), 7.35 (4H, s, Ar-H  4), 7.48 (4H, s, Ar-H  4),
7.57 (2H, s, NH  2), 8.10 (2H, s, NH  2), 8.32 (2H, s, NH  2)
ppm. 13C NMR (100 MHz, CDCl3–DMSO, 10 : 1): d ¼ 29.9 (CH3),
30.4 (CH3), 33.5 (C(CH3)3), 33.5 (C(CH3)3), 64.9 (OCH2), 67.5
(OCH2), 69.0 (OCH2), 70.6 (OCH2), 72.6 (OCH2), 118.4 (ArC),
120.4 (ArC), 121.8 (ArC), 125.6 (ArC), 126.1 (ArC), 126.3 (ArC),
127.1 (ArC), 127.5 (ArC), 128.0 (ArC), 128.2 (ArC), 137.3 (ArC),
146.4 (ArC), 147.5 (ArC), 153.7 (ArC), 154.0 (CO), 154.6 (ArC) and
167.5 (CO) ppm. FABMS: m/z: 1261.43 (M+). C66H80N6O11S4
(1260.48): calcd C 62.83, H 6.39, N 6.66. Found: C 62.59, H 6.23,
N 6.45.
Synthesis of receptor 4b
To compound 3 (150 mg, 0.147 mmol) in THF (10 mL), was
added p-tolyl isocyanate (43 mg, 0.320 mmol) and the mixture
was stirred for at room temperature for 24 h under argon. The
resulting precipitate was collected by ltration, washed with14752 | RSC Adv., 2015, 5, 14747–14755EtOH to give receptor 4b as a white solid. Recrystallization from
CHCl3–CH3CN (2 : 1) gave receptor 4b (163 mg, 86%) as white
solid. M.p. 205–207 C. IR: nmax (KBr)/cm
1: 3283, 2955, 1678,
1547, 1444, 1266, 1207, 1151, 1089, 999 and 815. 1H NMR
(300 MHz, CDCl3–DMSO, 10 : 1): d ¼ 1.27 (18H, s, tBu  2), 1.39
(18H, s, tBu  2), 2.28 (6H, s, CH3  2), 2.97 (4H, t, J ¼ 9.1 Hz,
OCH2  2), 3.40 (4H, br, OCH2  2), 3.63 (4H, s, OCH2  2), 3.85
(4H, t, J ¼ 9.1 Hz, OCH2  2), 4.58 (4H, s, OCH2CO  2), 6.96
(4H, d, J¼ 7.7 Hz, phenyl-H 4), 7.16 (4H, d, J¼ 7.7 Hz, phenyl-
H  4), 7.35 (4H, s, Ar-H  4), 7.48 (4H, s, Ar-H  4), 7.51 (2H, s,
NH  2), 8.10 (2H, s, NH  2), 8.22 (2H, s, NH  2) ppm. 13C
NMR (100 MHz, CDCl3–DMSO, 10 : 1): d ¼ 20.7 (CH3), 30.9
(CH3), 31.4 (CH3), 34.4 (C(CH3)3), 34.5 (C(CH3)3), 65.9 (OCH2),
68.6 (OCH2), 70.0 (OCH2), 71.6 (OCH2), 73.6 (OCH2), 119.4 (ArC),
126.6 (ArC), 127.0 (ArC), 127.3 (ArC), 128.2 (ArC), 129.0 (ArC),
129.5 (ArC), 131.9 (ArC), 135.7 (ArC), 136.1 (ArC), 147.4 (ArC),
148.5 (ArC), 154.4 (ArC), 154.8 (ArC), 155.1 (CO), 155.5 (ArC) and
168.5 (CO) ppm. FABMS: m/z: 1289.46 (M+). C68H84N6O11S4
(1289.69): calcd C 63.33, H 6.56, N 6.52. Found: C 62.56, H 6.56,
N 6.25.
Synthesis of receptor 4c
To compound 3 (150 mg, 0.147 mmol) in THF (10 mL), was
added p-triuoromethylphenyl isocyanate (59 mg, 0.320 mmol)
and the mixture was stirred for at room temperature for 24 h
under argon. The resulting precipitate was collected by ltra-
tion, washed with EtOH to give receptor 4c as a white solid.
Recrystallization from CHCl3–CH3CN (1 : 1) gave receptor 4c
(164 mg, 80%) as white solid. M.p. 207–210 C. IR: nmax
(KBr)/cm1: 3283, 2959, 1687, 1548, 1445, 1266, 1158, 1091,
1068 and 840. 1H NMR (300 MHz, CDCl3–DMSO, 10 : 1):
d ¼ 1.27 (18H, s, tBu  2), 1.40 (18H, s, tBu  2), 2.97 (4H, t,
J ¼ 9.1 Hz, OCH2  2), 3.40 (4H, br, OCH2  2), 3.63 (4H, s,
OCH2  2), 3.85 (4H, t, J ¼ 9.1 Hz, OCH2  2), 4.61 (4H, s,
OCH2CO 2), 7.36 (4H, s, Ar-H 4), 7.39–7.42 (8H, m, phenyl-H
 8), 7.49 (4H, s, Ar-H  4), 7.56 (2H, s, NH  2), 8.29 (2H, s, NH
 2), 8.69 (2H, s, NH  2) ppm. 13C NMR (100 MHz, CDCl3–
DMSO, 10 : 1): d ¼ 30.9 (CH3), 31.3 (CH3), 34.4 (C(CH3)3), 34.5
(C(CH3)3), 66.1 (OCH2), 68.5 (OCH2), 69.9 (OCH2), 71.6 (OCH2),
73.5 (OCH2), 118.1 (ArC), 122.9 (ArC), 123.9 (CF3), 124.2 (CF3),
125.6 (ArC), 125.8 (ArC), 125.9 (ArC), 126.4 (ArC), 126.9 (ArC),
127.0 (ArC), 128.2 (ArC), 147.4 (ArC), 148.4 (ArC), 154.6 (ArC),
154.8 (CO), 155.5 (ArC) and 167.5 (CO) ppm. FABMS: m/z:
1397.44 (M+). C68H78F6N6O11S4 (1397.63): calcd C 58.44, H 5.63,
N 6.01. Found: C 58.62, H 5.53, N 6.13.
Synthesis of receptor 4d
To compound 3 (150 mg, 0.147 mmol) in THF (10 mL), was
added 3,5-bis(triuoromethyl)phenyl isocyanate (82 mg,
0.320 mmol) and the mixture was stirred for at room tempera-
ture for 24 h under argon. The resulting precipitate was
collected by ltration, washed with EtOH to give receptor 4d as a
white solid. Recrystallization from CHCl3–CH3CN (1 : 1) gave
receptor 4d (187 mg, 83%) as white solid. M.p. 208–210 C. IR:
nmax (KBr)/cm
1: 3315, 2963, 1677, 1577, 1443, 1215, 1136, 1092,
1019 and 880. 1H NMR (300MHz, CDCl3–DMSO, 10 : 1): d¼ 1.32This journal is © The Royal Society of Chemistry 2015
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View Article Online(18H, s, tBu  2), 1.39 (18H, s, tBu  2), 3.01 (4H, t, J ¼ 9.1 Hz,
OCH2  2), 3.40 (4H, br, OCH2  2), 3.64 (4H, s, OCH2  2), 3.89
(4H, t, J ¼ 9.1 Hz, OCH2  2), 4.63 (4H, s, OCH2CO  2), 7.28
(2H, s, phenyl-H  2), 7.38 (4H, s, Ar-H  4), 7.42 (4H, s, phenyl-
H  4), 7.49 (4H, s, Ar-H  4), 7.82 (2H, s, NH  2), 8.49 (2H, s,
NH  2), 9.05 (2H, s, NH  2) ppm. 13C NMR (100 MHz, CDCl3–
DMSO, 10 : 1): d ¼ 30.8 (CH3), 31.2 (CH3), 34.3 (C(CH3)3), 34.4
(C(CH3)3), 65.8 (OCH2), 67.9 (OCH2), 69.7 (OCH2), 71.4 (OCH2),
73.4 (OCH2), 115.3 (ArC), 117.7 (ArC), 121.6 (ArC), 124.3 (CF3),
126.1 (ArC), 126.7 (ArC), 127.0 (ArC), 127.9 (ArC), 131.7 (ArC),
140.4 (ArC), 147.4 (ArC), 148.4 (ArC), 154.1 (ArC), 154.5 (ArC),
155.4 (CO), 155.5 (ArC) and 167.4 (CO) ppm. FABMS: m/z:
1533.48 (M+). C70H76F12N6O11S4 (1533.63): calcd C 54.82, H 4.99,
N 5.48. Found: C 54.63, H 5.05, N 5.35.
Synthesis of receptor 4e
To compound 3 (150 mg, 0.147 mmol) in THF (10 mL), was
added p-nitrophenyl isocyanate (53 mg, 0.320 mmol) and the
mixture was stirred for at room temperature for 24 h under
argon. The resulting precipitate was collected by ltration,
washed with EtOH to give receptor 4e as a pale yellow solid.
Recrystallization from CHCl3–CH3CN (3 : 1) gave receptor 4e (165
mg, 83%) as pale yellow solid. M.p. 212–215 C. IR: nmax (KBr)/
cm1: 3257, 2957, 1682, 1555, 1512, 1445, 1415, 1266, 1150, 1091
and 850. 1H NMR (300 MHz, CDCl3–DMSO, 10 : 1): d ¼ 1.27
(18H, s, tBu  2), 1.39 (18H, s, tBu  2), 2.97 (4H, t, J ¼ 9.1 Hz,
OCH2  2), 3.40 (4H, br, OCH2  2), 3.63 (4H, s, OCH2  2), 3.85
(4H, t, J¼ 9.1 Hz, OCH2 2), 4.58 (4H, s, OCH2CO 2) 7.40 (4H,
s, Ar-H  4), 8.57 (4H, s, Ar-H  4), 7.58 (4H, d, J ¼ 9.3 Hz,
phenyl-H  4), 7.66 (2H, s, NH  2), 8.06 (4H, d, J ¼ 9.3 Hz,
phenyl-H  4), 8.40 (2H, s, NH  2), 9.08 (2H, s, NH  2) ppm.
13C NMR (100 MHz, CDCl3–DMSO, 10 : 1): d ¼ 30.9 (CH3), 31.3
(CH3), 34.4 (C(CH3)3), 34.5 (C(CH3)3), 66.2 (OCH2), 69.0 (OCH2),
69.9 (OCH2), 71.7 (OCH2), 73.6 (OCH2), 118.1 (ArC), 124.9 (ArC),
126.2 (ArC), 127.1 (ArC), 127.7 (ArC), 128.0 (ArC), 128.4 (ArC),
142.6 (ArC), 144.5 (ArC), 147.5 (ArC), 147.3 (ArC), 147.9 (ArC),
148.2 (ArC), 154.0 (ArC), 154.2 (CO), 155.7 (ArC) and 168.5 (CO)
ppm. FABMS: m/z: 1351.57 (M+). C66H78N8O15S4 (1351.63): calcd
C 58.65, H 5.82, N 8.29. Found: C 58.81, H 5.75, N 8.12.
Determination of the association constants
The association constants were determined by using 1H NMR
spectroscopic titration experiments in a constant concentration
of host receptor (4.0  103 M) and varying the guest concen-
tration (0–8.0 103 M). The 1H NMR chemical shi of the urea
protons (NH) signal was used as a probe. The association
constant (Ka) for the complexes of receptor 4a–e were calculated
by nonlinear curve-tting analysis of the observed chemical
shis of the NH protons according to the literature procedure.14
1H NMR titration experiments
A solution of Bu4NX (X ¼ F, Cl, Br, I, AcO, PhCOO, H2PO4) in
CD3CN (4.0  103 M) was added to a CDCl3 solution of
receptor 4a–e in the absence or presence of KSO3CF3 in an NMR
tube. 1H NMR spectra were recorded aer addition of the
reactants and the temperature of the NMR probe was keptThis journal is © The Royal Society of Chemistry 2015constant at 27 C. The 1H NMR spectroscopic data of repre-
sentative complexes are given below:
Receptor 4aICl
. 1H NMR (300 MHz, CHCl3–DMSO–
CH3CN, 10 : 1 : 1, v/v): d ¼ 2.97 (4H, br, OCH2  2), 3.40 (4H, br,
OCH2  2), 3.63 (4H, br, OCH2  2), 3.85 (4H, br, OCH2  2),
4.59 (4H, s, OCH2O  2), 7.89 (2H, br, NHc  2), 8.10 (2H, br,
NHb  2) and 8.95 (2H, br, NHa  2) ppm.
Receptor 4bICl
. 1H NMR (300 MHz, CHCl3–DMSO–
CH3CN, 10 : 1 : 1, v/v): d ¼ 2.97 (4H, br, OCH2  2), 3.40 (4H, br,
OCH2  2), 3.63 (4H, br, OCH2  2), 3.85 (4H, br, OCH2  2),
4.68 (4H, s, OCH2O  2), 7.80 (2H, br, NHc  2), 8.09 (2H, br,
NHb  2) and 8.63 (2H, br, NHa  2) ppm.
Receptor 4cICl
. 1H NMR (300 MHz, CHCl3–DMSO–
CH3CN, 10 : 1 : 1, v/v): d ¼ 2.97 (4H, br, OCH2  2), 3.40 (4H, br,
OCH2  2), 3.63 (4H, br, OCH2  2), 3.85 (4H, br, OCH2  2),
4.68 (4H, s, OCH2O  2), 8.01 (2H, br, NHc  2), 8.20 (2H, br,
NHb  2) and 9.58 (2H, br, NHa  2) ppm.
Receptor 4dICl
. 1H NMR (300 MHz, CHCl3–DMSO–
CH3CN, 10 : 1 : 1, v/v): d ¼ 3.01 (4H, br, OCH2  2), 3.40 (4H, br,
OCH2  2), 3.64 (4H, br, OCH2  2), 3.89 (4H, br, OCH2  2),
4.63 (4H, s, OCH2O  2), 7.94 (2H, br, NHc  2), 8.33 (2H, br,
NHb  2) and 9.70 (2H, br, NHa  2) ppm.
Receptor 4eICl
. 1H NMR (300 MHz, CHCl3–DMSO–
CH3CN, 10 : 1 : 1, v/v): d ¼ 2.97 (4H, br, OCH2  2), 3.40 (4H, br,
OCH2  2), 3.63 (4H, br, OCH2  2), 3.85 (4H, br, OCH2  2),
4.60 (4H, s, OCH2O  2), 8.10 (2H, br, NHc  2), 8.18 (2H, br,
NHb  2) and 10.8 (2H, br, NHa  2) ppm.
Receptor 4eIK
+. 1H NMR (300 MHz, CHCl3–DMSO–CH3CN,
10 : 1 : 1, v/v): d ¼ 3.11 (4H, br, OCH2  2), 3.36–3.58 (4H, m,
OCH2  2), 3.64–3.90 (4H, m, OCH2  2), 4.08 (4H, br, OCH2 
2), 4.30–4.61 (4H, m, OCH2O  2), 8.10 (2H, s, NHc  2), 8.95
(2H, broad s, NHb  2) and 9.09 (2H, broad s, NHa  2) ppm.
Cl3[receptor 4eIK
+]. 1H NMR (300 MHz, CHCl3–DMSO–
CH3CN, 10 : 1 : 1, v/v): d ¼ 2.97 (4H, br, OCH2  2), 3.40 (4H, br,
OCH2  2), 3.63 (4H, br, OCH2  2), 3.85 (4H, br, OCH2  2),
4.60 (4H, s, OCH2O  2), 8.14 (2H, br, NHc  2), 8.58 (2H, br,
NHb  2) and 10.2 (2H, br, NHa  2) ppm.
Receptor 4eIBr
. 1H NMR (300 MHz, CHCl3–DMSO–
CH3CN, 10 : 1 : 1, v/v): d ¼ 2.97 (4H, br, OCH2  2), 3.40 (4H, br,
OCH2  2), 3.63 (4H, br, OCH2  2), 3.85 (4H, br, OCH2  2),
4.60 (4H, s, OCH2O  2), 7.52 (2H, br, NHc  2), 8.25 (2H, br,
NHb  2) and 9.27 (2H, br, NHa  2).
Br3[receptor 4eIK
+]. 1H NMR (300 MHz, CHCl3–DMSO–
CH3CN, 10 : 1 : 1, v/v): d ¼ 3.11 (4H, br, OCH2  2), 3.36–3.58
(4H, m, OCH2  2), 3.64–3.90 (4H, m, OCH2  2), 4.08 (4H, br,
OCH2  2), 4.30–4.61 (4H, m, OCH2O  2), 7.81 (2H, br, NHc 
2), 8.10 (2H, br, NHb  2) and 9.51 (2H, br, NHa  2).Crystallographic analysis of receptors 4b and 4e
Crystal data for 4b. C68H84N6O11S4$½(H2O)$1½(CHCl3),Mr¼
1477.71. Monoclinic, P21/n; a ¼ 18.8935 (13), b ¼ 23.9302 (16),
c ¼ 33.589 (2)A; b ¼ 91.5063 (12); V ¼ 15 181.2 (17)A3; Z ¼ 8;
Dx ¼ 1.293 Mg m3; F(000) ¼ 6224; T ¼ 210(2) K; m (Mo-Ka) ¼
0.34 mm1; l ¼ 0.71073A, crystal size 0.71  0.54  0.32 mm3.
Crystals were colorless blocks. Diﬀraction data were measured
on a Bruker APEX 2 CCD diﬀractometer equipped with graphiteRSC Adv., 2015, 5, 14747–14755 | 14753
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View Article Onlinemonochromated MoKa radiation by thin-slice u-scans.15 134 900
measured reections, 31 218 independent reections
(Rint ¼ 0.049) to qmax ¼ 26.5; 19 539 reections with I > 2s(I).
The structure was determined by direct methods using the
SHELXS program and rened by the full-matrix least-squares
method, on F2, in SHELXL-2013/14.16,17 The non-hydrogen
atoms were rened with anisotropic thermal parameters.
Hydrogen atoms on C were included in idealized positions and
their Uiso values were set to ride on the Ueq values of the parent
atoms. H atoms on N were freely rened. At the conclusion of
the renement, wR2 ¼ 0.173 (all data) and R1 ¼ 0.056 (observed
data), 1903 parameters, Dimax ¼ 0.56 eA3; 465 restraints, Dimin
¼ 0.43 eA3. The platon squeeze procedure was used to model
two of the three unique CHCl3 molecules due to severe
disorder.18 Two-fold disorder was modelled in some tBu groups,
in parts of one of the crown ether chains and the other CHCl3
molecule. H atoms on watermolecule O(23) could not be located
in diﬀerence maps, so were not included in the model.†
Crystal data for 4e. C66H78N8O15S4$½(CHCl3)$3(MeCN),
Mr ¼ 1534.44. Monoclinic, P21/c; a ¼ 17.7980 (10), b ¼ 26.7870
(16), c¼ 32.552 (2)A; b¼ 96.384 (4); V¼ 15 423.1 (16)A3; Z¼ 8;
Dx ¼ 1.322 Mg m3; F(000) ¼ 6472; T ¼ 100 (2) K; m (Mo-
Ka) ¼ 0.31 mm1; l ¼ 0.7749 A, crystal size 0.25  0.25  0.02
mm3. Crystals were colorless plates. Diﬀraction data were
measured on a Bruker APEX 2 CCD diﬀractometer at station
11.3.1 of the ALS using synchrotron radiation by thin-slice u-
scans.15 155 885 measured reections, 50 956 independent
reections (Rint¼ 0.052) to qmax¼ 34.8; 35 702 reections with I
> 2s(I). Structure solution with SHELXT and renement as
above.16,17 Hydrogen atoms on C and some N atoms were
included in idealized positions and their Uiso values were set to
ride on the Ueq values of the parent atoms. H atoms on the
remaining N atoms were freely rened. At the conclusion of the
renement, wR2 ¼ 0.294 (all data) and R1 ¼ 0.086 (observed
data), 2055 parameters, Dimax ¼ 2.44 eA3; 656 restraints, Dimin
¼ 1.86 eA3. The platon squeeze procedure was used to model
four of the six unique MeCN molecules due to severe disorder.18
Two-fold disorder wasmodelled in some tBu groups and in parts
of one the crown ether chains and one HN-p-C6H4NO2 group.†
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